Free Trial

Everpure (P) Financials

Everpure logo
$72.62 -0.64 (-0.88%)
Closing price 03:59 PM Eastern
Extended Trading
$73.00 +0.38 (+0.53%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Everpure

Annual Income Statements for Everpure

This table shows Everpure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2017 1/31/2017 1/31/2018 1/31/2019 2/2/2020 1/31/2021 2/6/2022 2/5/2023 2/4/2024 2/2/2025 2/1/2026
Net Income / (Loss) Attributable to Common Shareholders
-222 -245 -160 -178 -201 -282 -143 73 61 107 188
Consolidated Net Income / (Loss)
-222 -245 -160 -178 -201 -282 -143 73 61 107 188
Net Income / (Loss) Continuing Operations
-222 -245 -160 -178 -201 -282 -143 73 61 107 188
Total Pre-Tax Income
-220 -243 -156 -177 -195 -270 -128 92 91 148 224
Total Operating Income
-221 -245 -167 -169 -191 -261 -98 84 54 85 115
Total Gross Profit
487 476 671 902 1,134 1,149 1,473 1,898 2,021 2,213 2,578
Total Revenue
739 728 1,025 1,360 1,643 1,684 2,181 2,753 2,831 3,168 3,663
Operating Revenue
739 728 1,025 1,360 1,643 1,684 2,181 2,753 2,831 3,168 3,663
Total Cost of Revenue
252 252 354 458 510 535 708 856 809 955 1,085
Operating Cost of Revenue
252 252 354 458 510 535 708 856 809 955 1,085
Total Operating Expenses
708 721 838 1,072 1,325 1,410 1,571 1,814 1,968 2,127 2,463
Selling, General & Admin Expense
85 85 95 138 163 182 190 238 252 286 318
Marketing Expense
348 360 464 584 728 716 799 884 945 1,021 1,181
Research & Development Expense
246 246 279 350 434 480 582 693 737 804 963
Restructuring Charge
- - - 0.00 0.00 31 0.00 0.00 34 16 0.00
Total Other Income / (Expense), net
1.63 1.63 11 -8.02 -3.38 -9.13 -30 8.30 37 63 109
Other Income / (Expense), net
1.63 1.63 11 -8.02 -3.38 -9.13 -30 8.30 37 63 109
Income Tax Expense
1.89 1.89 3.89 1.09 6.32 12 15 19 29 41 36
Basic Earnings per Share
($1.14) ($1.26) ($0.76) ($0.77) ($0.79) ($1.05) ($0.50) $0.24 $0.20 $0.33 $0.57
Weighted Average Basic Shares Outstanding
194.71M 206.61M 211.61M 232.04M 252.82M 267.82M 285.88M 299.48M 311.83M 325.77M 328.54M
Diluted Earnings per Share
($1.14) ($1.26) ($0.76) ($0.77) ($0.79) ($1.05) ($0.50) $0.23 $0.19 $0.31 $0.55
Weighted Average Diluted Shares Outstanding
194.71M 206.61M 211.61M 232.04M 252.82M 267.82M 285.88M 339.18M 332.57M 342.70M 342.99M
Weighted Average Basic & Diluted Shares Outstanding
194.71M 194.71M 211.61M 232.04M 252.82M 267.82M 298.50M 308.05M 324.91M 326.02M 330.46M

Quarterly Income Statements for Everpure

This table shows Everpure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/5/2023 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026
Net Income / (Loss) Attributable to Common Shareholders
70 65 -35 36 64 42 -14 47 55 100 24
Consolidated Net Income / (Loss)
70 65 -35 36 64 42 -14 47 55 100 24
Net Income / (Loss) Continuing Operations
70 65 -35 36 64 42 -14 47 55 100 24
Total Pre-Tax Income
79 71 -28 44 77 54 0.48 51 66 108 34
Total Operating Income
74 57 -42 25 60 42 -31 4.87 54 87 20
Total Gross Profit
553 569 496 540 583 594 536 604 697 740 723
Total Revenue
763 790 693 764 831 880 778 861 964 1,059 1,053
Operating Revenue
763 790 693 764 831 880 778 861 964 1,059 1,053
Total Cost of Revenue
210 221 198 224 248 286 242 257 267 319 330
Operating Cost of Revenue
210 221 198 224 248 286 242 257 267 319 330
Total Operating Expenses
479 511 537 515 523 552 567 599 643 653 703
Selling, General & Admin Expense
65 59 77 69 67 73 67 72 93 86 96
Marketing Expense
232 248 251 250 256 264 279 286 294 323 348
Research & Development Expense
182 187 194 195 200 215 222 242 256 243 259
Total Other Income / (Expense), net
5.18 13 14 19 17 12 32 46 12 20 14
Other Income / (Expense), net
5.18 13 14 19 17 12 32 46 12 20 14
Income Tax Expense
9.01 5.36 7.33 8.64 13 12 14 3.45 11 7.27 9.79
Basic Earnings per Share
$0.22 $0.22 ($0.11) $0.11 $0.19 $0.14 ($0.04) $0.14 $0.17 $0.30 $0.07
Weighted Average Basic Shares Outstanding
314.15M 311.83M 322.59M 326.33M 327.68M 325.77M 326.54M 327.59M 329.57M 328.54M 331.15M
Diluted Earnings per Share
$0.21 $0.22 ($0.11) $0.10 $0.19 $0.13 ($0.04) $0.14 $0.16 $0.29 $0.07
Weighted Average Diluted Shares Outstanding
330.26M 332.57M 322.59M 343.44M 340.56M 342.70M 326.54M 337.73M 345.75M 342.99M 343.49M
Weighted Average Basic & Diluted Shares Outstanding
315.97M 324.91M 325.23M 327.69M 326.24M 326.02M 326.83M 328.64M 330.17M 330.46M 332.40M

Annual Cash Flow Statements for Everpure

This table details how cash moves in and out of Everpure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2017 1/31/2017 1/31/2018 1/31/2019 2/2/2020 1/31/2021 2/6/2022 2/5/2023 2/4/2024 2/2/2025 2/1/2026
Net Change in Cash & Equivalents
-415 -421 62 205 -86 -30 129 115 121 26 127
Net Cash From Operating Activities
-14 -14 73 164 190 188 410 767 678 754 880
Net Cash From Continuing Operating Activities
-14 -14 73 164 190 188 410 767 678 754 880
Net Income / (Loss) Continuing Operations
-222 -245 -160 -178 -201 -282 -143 73 61 107 188
Consolidated Net Income / (Loss)
-222 -245 -160 -178 -201 -282 -143 73 61 107 188
Depreciation Expense
50 50 62 71 90 70 83 100 124 127 148
Non-Cash Adjustments To Reconcile Net Income
119 118 153 206 255 286 330 369 385 468 510
Changes in Operating Assets and Liabilities, net
38 62 18 45 19 85 108 225 107 52 34
Net Cash From Investing Activities
-442 -447 -57 -511 -325 -418 -153 -221 3.25 -218 -108
Net Cash From Continuing Investing Activities
-442 -447 -57 -511 -325 -418 -153 -221 3.25 -218 -108
Purchase of Property, Plant & Equipment
-77 -77 -65 -100 -88 -95 -102 -158 -195 -227 -264
Acquisitions
-1.00 -1.00 0.00 -14 -61 -340 0.00 - 0.00 0.00 -4.26
Purchase of Investments
-527 -527 -203 -665 -796 -574 -618 -501 -472 -503 -462
Divestitures
- - - - - - - - 0.00 0.00 52
Sale and/or Maturity of Investments
163 163 211 273 619 595 567 440 665 513 570
Other Investing Activities, net
- -5.60 - -5.00 0.00 -5.00 - -1.99 5.00 -1.75 -0.28
Net Cash From Financing Activities
41 41 47 552 49 200 -128 -431 -560 -510 -645
Net Cash From Continuing Financing Activities
41 41 47 552 49 200 -128 -431 -560 -510 -645
Repayment of Debt
0.00 - 0.00 -6.10 -12 0.00 -2.14 -257 -586 -8.12 -106
Repurchase of Common Equity
0.00 0.00 0.00 -85 -15 -135 -200 -219 -136 -374 -343
Issuance of Debt
0.00 15 0.00 562 0.00 252 0.00 0.00 107 0.00 0.00
Issuance of Common Equity
26 26 22 33 43 32 37 40 45 52 56
Other Financing Activities, net
15 - 25 47 33 51 38 5.18 9.79 -179 -253
Cash Interest Paid
0.00 - 0.00 0.37 0.72 2.28 5.02 1.19 5.83 7.18 2.27
Cash Income Taxes Paid
2.87 2.87 3.09 4.70 4.82 11 13 14 29 38 33

Quarterly Cash Flow Statements for Everpure

This table details how cash moves in and out of Everpure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/5/2023 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026
Net Change in Cash & Equivalents
120 173 198 70 -72 -170 22 150 -36 -9.13 -16
Net Cash From Operating Activities
158 244 222 227 97 209 284 212 116 268 180
Net Cash From Continuing Operating Activities
158 244 222 227 97 209 284 212 116 268 180
Net Income / (Loss) Continuing Operations
70 65 -35 36 64 42 -14 47 55 100 24
Consolidated Net Income / (Loss)
70 65 -35 36 64 42 -14 47 55 100 24
Depreciation Expense
32 33 34 36 28 29 34 36 38 40 40
Non-Cash Adjustments To Reconcile Net Income
93 92 126 114 113 115 105 105 153 147 137
Changes in Operating Assets and Liabilities, net
-36 54 97 41 -107 22 159 24 -129 -20 -21
Net Cash From Investing Activities
-37 -42 -48 -85 39 -125 -112 130 -44 -82 -45
Net Cash From Continuing Investing Activities
-37 -42 -48 -85 39 -125 -112 130 -44 -82 -45
Purchase of Property, Plant & Equipment
-45 -44 -49 -60 -62 -56 -72 -62 -63 -67 -68
Purchase of Investments
-105 -120 -165 -105 -44 -189 -115 -141 -70 -136 -113
Sale and/or Maturity of Investments
113 117 166 81 145 122 75 333 41 120 136
Net Cash From Financing Activities
-0.91 -30 25 -72 -209 -253 -150 -192 -108 -195 -151
Net Cash From Continuing Financing Activities
-0.91 -30 25 -72 -209 -253 -150 -192 -108 -195 -151
Repayment of Debt
-7.52 -1.62 -1.10 -2.84 -1.79 -2.40 -1.13 -102 -2.32 -0.09 -0.61
Repurchase of Common Equity
-22 -21 0.00 - -182 -192 -120 -42 -53 -127 -84
Issuance of Common Equity
24 - 25 - 26 - 27 - 29 - 30
Other Financing Activities, net
-1.70 -6.54 0.75 -70 -51 -59 -56 -48 -81 -68 -96
Cash Interest Paid
1.85 1.85 1.74 1.78 1.79 1.88 1.43 0.70 0.15 - 0.00
Cash Income Taxes Paid
5.47 9.21 3.54 20 6.37 8.56 8.27 13 3.53 7.85 0.88

Annual Balance Sheets for Everpure

This table presents Everpure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2017 1/31/2017 1/31/2018 1/31/2019 2/2/2020 1/31/2021 2/6/2022 2/5/2023 2/4/2024 2/2/2025 2/1/2026
Total Assets
900 900 1,124 1,973 2,364 2,819 3,135 3,543 3,656 3,964 4,674
Total Current Assets
780 780 943 1,702 1,890 1,908 2,192 2,475 2,498 2,567 3,063
Cash & Equivalents
184 184 244 448 363 337 466 581 703 724 855
Short-Term Investments
363 363 353 749 937 916 947 1,001 829 798 692
Accounts Receivable
169 169 243 379 459 461 542 612 662 681 945
Inventories, net
23 23 34 45 39 47 39 50 43 43 76
Prepaid Expenses
25 25 48 52 57 90 116 161 173 223 356
Other Current Assets
16 16 21 29 37 57 82 69 89 99 139
Plant, Property, & Equipment, net
82 82 89 125 123 163 195 272 353 462 587
Total Noncurrent Assets
38 38 91 146 351 748 748 796 805 935 1,024
Long-Term Investments
- - - - - 11 11 11 9.60 13 7.69
Goodwill
- - 0.00 11 38 359 359 361 361 361 365
Intangible Assets
6.56 6.56 5.06 20 58 77 63 49 33 19 7.35
Other Noncurrent Operating Assets
31 31 85 115 255 302 316 375 401 542 644
Total Liabilities & Shareholders' Equity
900 900 1,124 1,973 2,364 2,819 3,135 3,543 3,656 3,964 4,674
Total Liabilities
421 421 550 1,235 1,534 2,069 2,381 2,602 2,386 2,657 3,229
Total Current Liabilities
273 273 363 510 615 761 952 1,750 1,366 1,597 1,910
Accounts Payable
53 53 84 103 78 68 71 67 83 112 153
Accrued Expenses
22 22 27 40 47 62 79 124 136 157 184
Current Deferred Revenue
158 158 191 267 356 438 563 718 852 954 1,181
Current Employee Benefit Liabilities
39 39 60 100 107 161 205 233 250 230 347
Other Current Liabilities
1.36 1.36 - 0.00 27 32 35 34 45 43 44
Total Noncurrent Liabilities
148 148 187 725 919 1,309 1,429 852 1,020 1,061 1,319
Noncurrent Deferred Revenue
145 145 183 269 341 405 517 668 742 841 1,046
Other Noncurrent Operating Liabilities
3.16 3.16 4.03 6.27 101 148 125 185 178 219 272
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
478 478 574 738 830 750 754 941 1,270 1,306 1,446
Total Preferred & Common Equity
478 478 574 738 830 750 754 941 1,270 1,306 1,446
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
478 478 574 738 830 750 754 941 1,270 1,306 1,446
Common Stock
1,281 1,281 1,480 1,820 2,108 2,308 2,471 2,494 2,750 2,675 2,625
Retained Earnings
-802 -802 -904 -1,082 -1,283 -1,565 -1,708 -1,537 -1,476 -1,369 -1,181
Accumulated Other Comprehensive Income / (Loss)
-0.56 -0.56 -1.92 -0.34 5.45 7.41 -8.37 -16 -3.78 0.95 1.71

Quarterly Balance Sheets for Everpure

This table presents Everpure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 11/6/2022 5/7/2023 8/6/2023 11/5/2023 5/5/2024 8/4/2024 11/3/2024 5/4/2025 8/3/2025 11/2/2025 5/3/2026
Total Assets
3,253 2,959 3,134 3,356 3,624 3,781 3,854 3,810 4,027 4,218 4,750
Total Current Assets
2,209 1,868 2,041 2,247 2,448 2,553 2,560 2,400 2,525 2,652 3,050
Cash & Equivalents
796 378 409 529 901 965 895 739 888 853 838
Short-Term Investments
669 806 820 822 823 855 754 840 650 679 667
Accounts Receivable
436 391 525 636 423 417 578 411 530 621 887
Inventories, net
60 52 47 46 41 44 42 38 47 82 78
Prepaid Expenses
179 172 168 139 174 185 204 271 305 308 437
Other Current Assets
69 69 71 74 85 87 87 101 105 109 143
Plant, Property, & Equipment, net
249 303 326 338 368 397 431 504 544 566 614
Total Noncurrent Assets
796 789 767 771 808 832 863 907 958 1,000 1,086
Long-Term Investments
11 9.96 9.96 9.96 9.60 15 11 19 20 19 8.29
Goodwill
361 361 361 361 361 361 361 361 361 365 365
Intangible Assets
53 45 41 37 29 27 23 15 11 9.41 5.34
Other Noncurrent Operating Assets
370 372 355 363 408 428 468 511 565 607 707
Total Liabilities & Shareholders' Equity
3,253 2,959 3,134 3,356 3,624 3,781 3,854 3,810 4,027 4,218 4,750
Total Liabilities
2,412 2,053 2,148 2,207 2,250 2,328 2,444 2,566 2,708 2,816 3,308
Total Current Liabilities
1,623 1,106 1,204 1,238 1,226 1,283 1,445 1,495 1,534 1,605 1,886
Accounts Payable
103 71 98 101 56 68 102 84 112 128 173
Accrued Expenses
109 121 129 141 128 119 142 158 157 160 182
Current Deferred Revenue
647 732 770 802 860 869 897 969 1,006 1,029 1,250
Current Employee Benefit Liabilities
159 143 165 150 138 177 156 142 213 245 236
Other Current Liabilities
31 38 42 44 45 50 48 41 46 44 45
Total Noncurrent Liabilities
789 947 944 969 1,023 1,045 999 1,072 1,173 1,210 1,421
Noncurrent Deferred Revenue
601 663 667 695 741 754 784 858 905 932 1,128
Other Noncurrent Operating Liabilities
188 184 177 174 182 191 215 214 268 279 294
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
841 906 986 1,148 1,374 1,453 1,411 1,244 1,319 1,403 1,442
Total Preferred & Common Equity
841 906 986 1,148 1,374 1,453 1,411 1,244 1,319 1,403 1,442
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
841 906 986 1,148 1,374 1,453 1,411 1,244 1,319 1,403 1,442
Common Stock
2,476 2,521 2,611 2,700 2,890 2,926 2,821 2,625 2,653 2,682 2,601
Retained Earnings
-1,612 -1,604 -1,612 -1,541 -1,511 -1,475 -1,411 -1,383 -1,336 -1,281 -1,157
Accumulated Other Comprehensive Income / (Loss)
-24 -11 -13 -10 -5.58 2.71 1.02 1.83 1.92 2.01 -1.61

Annual Metrics And Ratios for Everpure

This table displays calculated financial ratios and metrics derived from Everpure's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2017 1/31/2017 1/31/2018 1/31/2019 2/2/2020 1/31/2021 2/6/2022 2/5/2023 2/4/2024 2/2/2025 2/1/2026
DEI Shares Outstanding
- - - - - - - - - - 330,171,649.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 330,171,649.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.57
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-155 -247 -117 -118 -134 -183 -69 66 36 62 96
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.39% 2.65% 4.38% 6.66%
Earnings before Interest and Taxes (EBIT)
-220 -243 -156 -177 -195 -270 -128 92 91 148 224
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-169 -193 -94 -85 -78 -171 -14 192 215 274 372
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-128 -247 -162 -132 -152 -416 56 261 130 19 78
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-68 -68 -23 -9.86 7.97 242 117 -77 -171 -128 -109
Increase / (Decrease) in Invested Capital
-27 0.00 45 13 18 234 -124 -194 -94 43 19
Book Value per Share
$2.39 $2.46 $2.65 $3.05 $3.19 $2.75 $2.60 $3.11 $4.02 $4.00 $4.38
Tangible Book Value per Share
$2.36 $2.43 $2.63 $2.92 $2.82 $1.15 $1.15 $1.75 $2.77 $2.84 $3.25
Total Capital
478 478 574 1,188 1,307 1,506 1,541 1,516 1,370 1,406 1,446
Total Debt
0.00 0.00 0.00 450 477 756 787 575 100 100 0.00
Total Long-Term Debt
0.00 0.00 0.00 450 477 756 787 0.00 100 0.00 0.00
Net Debt
-547 -547 -597 -748 -822 -508 -637 -1,018 -1,441 -1,434 -1,555
Capital Expenditures (CapEx)
77 77 65 100 88 95 102 158 195 227 264
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-40 -40 -17 -5.46 -24 -106 -173 -283 -399 -451 -394
Debt-free Net Working Capital (DFNWC)
507 507 581 1,192 1,276 1,148 1,240 1,299 1,132 1,071 1,154
Net Working Capital (NWC)
507 507 581 1,192 1,276 1,148 1,240 725 1,132 971 1,154
Net Nonoperating Expense (NNE)
67 -1.64 43 60 67 99 74 -6.60 -25 -45 -92
Net Nonoperating Obligations (NNO)
-547 -547 -597 -748 -822 -508 -637 -1,018 -1,441 -1,434 -1,555
Total Depreciation and Amortization (D&A)
50 50 62 92 117 99 115 100 124 127 148
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.26) $0.00 ($0.84) ($0.77) ($0.79) ($1.05) ($0.50) $0.24 $0.20 $0.33 $0.57
Adjusted Weighted Average Basic Shares Outstanding
206.61M 194.50M 229.24M 244.93M 534.06M 280.34M 285.88M 299.48M 311.83M 325.77M 328.54M
Adjusted Diluted Earnings per Share
($1.26) $0.00 ($0.84) ($0.77) ($0.79) ($1.05) ($0.50) $0.23 $0.19 $0.31 $0.55
Adjusted Weighted Average Diluted Shares Outstanding
206.61M 194.50M 229.24M 244.93M 534.06M 280.34M 285.88M 339.18M 332.57M 342.70M 342.99M
Adjusted Basic & Diluted Earnings per Share
($1.26) $0.00 ($0.84) ($0.77) ($0.79) ($1.05) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
194.71M 194.71M 211.61M 232.04M 252.82M 267.82M 298.50M 308.05M 324.91M 326.02M 330.46M
Normalized Net Operating Profit after Tax (NOPAT)
-134 -150 -117 -118 -134 -161 -69 66 59 73 96
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Everpure

This table displays calculated financial ratios and metrics derived from Everpure's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/5/2023 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026
DEI Shares Outstanding
- - - - - - - - - 330,171,649.00 330,460,930.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 330,171,649.00 330,460,930.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.30 0.07
Growth Metrics
- - - - - - - - - - -
Revenue Growth
12.84% -2.52% 17.68% 10.91% 8.94% 11.40% 12.26% 12.73% 16.05% - 35.25%
EBITDA Growth
246.59% -5.30% 120.61% 161.40% -5.85% -19.46% 447.19% 7.85% -1.01% - 116.23%
EBIT Growth
1,156.45% -12.91% 53.91% 9,575.76% -3.21% -23.22% 101.75% 14.12% -14.49% - 6,897.93%
NOPAT Growth
5,884.16% -10.36% 41.83% -79.30% -24.87% -37.49% 3,182.29% -77.34% -9.02% - -98.43%
Net Income Growth
9,043.96% -12.13% 48.06% 601.39% -9.59% -35.15% 60.02% 32.08% -13.88% - 272.05%
EPS Growth
0.00% -8.33% 50.00% 600.00% -9.52% -40.91% 63.64% 40.00% -15.79% - 275.00%
Operating Cash Flow Growth
2.42% 4.89% 27.85% 122.99% -38.78% -14.69% 28.19% -6.37% 19.59% - -36.55%
Free Cash Flow Firm Growth
-38.23% -42.16% -68.72% -28.87% -26.49% -106.51% 2,020.68% -126.10% -49.27% - -118.87%
Invested Capital Growth
-83.67% -121.52% -37.99% -85.21% -32.54% 25.03% 2.14% 15.47% 0.88% - 72.10%
Revenue Q/Q Growth
10.77% 3.54% -12.20% 10.14% 8.81% 5.87% -11.52% 10.60% 12.02% - -0.57%
EBITDA Q/Q Growth
261.92% -6.65% -93.96% 1,181.13% 30.36% -20.15% -58.97% 152.52% 19.65% - -49.90%
EBIT Q/Q Growth
17,235.15% -10.83% -139.10% 260.08% 73.40% -29.26% -99.11% 10,348.55% 29.93% - -68.50%
NOPAT Q/Q Growth
-32.00% -19.39% -155.13% 168.49% 146.82% -32.93% 2,618.78% -99.50% 890.92% - -82.57%
Net Income Q/Q Growth
1,089.30% -7.03% -153.50% 201.90% 78.39% -33.32% -132.98% 436.68% 16.32% - -75.98%
EPS Q/Q Growth
1,150.00% 4.76% -150.00% 190.91% 90.00% -31.58% -130.77% 450.00% 14.29% - -75.86%
Operating Cash Flow Q/Q Growth
55.91% 54.28% -9.38% 2.30% -57.20% 114.97% 36.18% -25.28% -45.33% - -32.77%
Free Cash Flow Firm Q/Q Growth
-44.42% 25.24% -71.19% 254.69% -42.56% -111.09% 9,485.17% -104.37% 211.65% - -369.36%
Invested Capital Q/Q Growth
26.10% -51.55% -52.19% -8.65% 47.11% 14.27% -98.65% 6.15% 37.99% - 35.16%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
72.46% 71.98% 71.48% 70.71% 70.14% 67.51% 68.87% 70.19% 72.31% - 68.70%
EBITDA Margin
14.56% 13.12% 0.90% 10.50% 12.58% 9.49% 4.40% 10.05% 10.73% - 7.03%
Operating Margin
9.73% 7.27% -6.02% 3.26% 7.18% 4.83% -4.00% 0.57% 5.59% - 1.89%
EBIT Margin
10.41% 8.96% -3.99% 5.80% 9.25% 6.18% 0.06% 5.87% 6.81% - 3.22%
Profit (Net Income) Margin
9.23% 8.29% -5.05% 4.67% 7.66% 4.82% -1.80% 5.47% 5.68% - 2.29%
Tax Burden Percent
88.66% 92.43% 126.46% 80.50% 82.82% 78.06% -2,891.53% 93.17% 83.41% - 71.09%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Effective Tax Rate
11.34% 7.57% 0.00% 19.50% 17.18% 21.94% 2,991.53% 6.83% 16.59% - 28.91%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)
7.07% 5.55% 8.22% 11.19% 10.14% 8.29% 9.76% 10.04% 9.27% - 16.85%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Return on Assets (OROA)
8.98% 7.05% -3.56% 5.05% 7.89% 5.14% 0.05% 5.04% 5.88% - 2.96%
Return on Assets (ROA)
7.96% 6.52% -4.50% 4.07% 6.54% 4.01% -1.57% 4.70% 4.90% - 2.10%
Return on Common Equity (ROCE)
7.07% 5.55% 8.22% 11.19% 10.14% 8.29% 9.76% 10.04% 9.27% - 16.85%
Return on Equity Simple (ROE_SIMPLE)
6.13% 0.00% 6.82% 9.39% 9.20% 0.00% 0.00% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
66 53 -29 20 49 33 901 4.54 45 81 14
NOPAT Margin
8.62% 6.72% -4.22% 2.62% 5.95% 3.77% 115.78% 0.53% 4.66% - 1.35%
Net Nonoperating Expense Percent (NNEP)
0.43% 1.01% -0.42% 1.09% 1.01% 0.65% -58.45% 2.59% 0.63% - 0.66%
Return On Investment Capital (ROIC_SIMPLE)
5.27% 3.87% - - 3.27% 2.36% 67.06% 0.34% 3.21% 5.62% 0.98%
Cost of Revenue to Revenue
27.54% 28.02% 28.52% 29.29% 29.86% 32.49% 31.13% 29.81% 27.69% - 31.30%
SG&A Expenses to Revenue
8.49% 7.51% 11.07% 9.09% 8.10% 8.26% 8.62% 8.31% 9.67% - 9.16%
R&D to Revenue
23.87% 23.66% 27.95% 25.60% 24.08% 24.44% 28.48% 28.11% 26.58% - 24.61%
Operating Expenses to Revenue
62.73% 64.72% 77.50% 67.46% 62.96% 62.69% 72.88% 69.62% 66.72% - 66.81%
Earnings before Interest and Taxes (EBIT)
79 71 -28 44 77 54 0.48 51 66 108 34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
111 104 6.26 80 105 83 34 86 103 148 74
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.50 10.51 12.35 12.15 11.84 16.93 12.54 13.51 23.12 - 16.41
Price to Tangible Book Value (P/TBV)
14.54 15.25 17.26 16.58 16.27 23.88 17.98 18.83 31.53 - 22.08
Price to Revenue (P/Rev)
3.83 4.72 5.78 5.87 5.42 6.98 4.79 5.32 9.31 - 6.01
Price to Earnings (P/E)
155.04 217.74 181.14 129.36 128.69 207.19 122.09 127.99 248.81 - 104.61
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.65% 0.46% 0.55% 0.77% 0.78% 0.48% 0.82% 0.78% 0.40% - 0.96%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Revenue (EV/Rev)
3.38 4.21 5.23 5.29 4.92 6.53 4.33 4.85 8.87 - 5.63
Enterprise Value to EBITDA (EV/EBITDA)
43.68 55.39 60.96 52.87 51.37 75.34 46.61 52.65 100.37 - 53.78
Enterprise Value to EBIT (EV/EBIT)
95.42 131.47 124.75 95.44 92.14 139.90 80.11 89.21 180.49 - 85.98
Enterprise Value to NOPAT (EV/NOPAT)
228.12 328.58 240.82 169.66 191.32 335.96 202.62 280.64 578.47 - 152.06
Enterprise Value to Operating Cash Flow (EV/OCF)
14.47 17.57 21.13 18.71 19.17 27.44 17.28 20.28 37.64 - 28.54
Enterprise Value to Free Cash Flow (EV/FCFF)
103.09 91.73 113.48 71.20 130.77 1,096.45 220.21 1,137.52 593.10 - 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.09 0.08 0.07 0.07 0.07 0.08 0.08 0.00 0.00 - 0.00
Long-Term Debt to Equity
0.09 0.08 0.07 0.07 0.00 0.00 0.00 0.00 0.00 - 0.00
Financial Leverage
-1.09 -1.11 -1.20 -1.18 -1.10 -1.12 -1.20 -1.19 -1.11 - -1.12
Leverage Ratio
3.32 3.26 2.89 2.83 2.82 2.96 2.84 2.82 2.87 - 3.19
Compound Leverage Factor
3.32 3.26 2.89 2.83 2.82 2.96 2.84 2.82 2.87 - 3.19
Debt to Total Capital
8.01% 7.30% 6.78% 6.44% 6.62% 7.11% 7.44% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 6.62% 7.11% 7.44% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital
8.01% 7.30% 6.78% 6.44% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
91.99% 92.70% 93.22% 93.56% 93.38% 92.89% 92.56% 100.00% 100.00% - 100.00%
Debt to EBITDA
0.45 0.47 0.40 0.33 0.34 0.36 0.33 0.00 0.00 - 0.00
Net Debt to EBITDA
-5.71 -6.70 -6.49 -5.76 -5.29 -5.23 -4.95 0.00 0.00 - 0.00
Long-Term Debt to EBITDA
0.45 0.47 0.40 0.33 0.00 0.00 0.00 0.00 0.00 - 0.00
Debt to NOPAT
2.37 2.76 1.57 1.07 1.26 1.62 1.44 0.00 0.00 - 0.00
Net Debt to NOPAT
-29.82 -39.75 -25.65 -18.49 -19.72 -23.30 -21.53 0.00 0.00 - 0.00
Long-Term Debt to NOPAT
2.37 2.76 1.57 1.07 0.00 0.00 0.00 0.00 0.00 - 0.00
Altman Z-Score
3.61 4.00 5.13 5.24 4.80 5.65 4.28 4.65 7.66 - 5.10
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.82 1.83 2.00 1.99 1.77 1.61 1.61 1.65 1.65 - 1.62
Quick Ratio
1.61 1.61 1.75 1.74 1.54 1.38 1.33 1.35 1.34 - 1.27
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
117 147 42 150 86 -9.54 896 -39 44 63 -169
Operating Cash Flow to CapEx
351.59% 560.99% 453.73% 377.44% 156.98% 371.76% 392.47% 342.04% 182.90% - 263.34%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.86 0.79 0.89 0.87 0.85 0.83 0.88 0.86 0.86 - 0.92
Accounts Receivable Turnover
5.32 4.44 7.20 6.39 5.07 4.72 7.79 7.08 5.81 - 6.07
Inventory Turnover
15.80 17.44 17.97 18.73 20.30 22.36 25.57 22.86 16.97 - 20.30
Fixed Asset Turnover
9.73 9.06 8.75 8.33 8.01 7.78 7.46 7.12 6.98 - 7.05
Accounts Payable Turnover
8.21 10.80 13.09 10.27 8.77 9.79 14.33 11.46 9.15 - 9.12
Days Sales Outstanding (DSO)
68.62 82.18 50.66 57.10 72.01 77.37 46.83 51.58 62.82 - 60.17
Days Inventory Outstanding (DIO)
23.10 20.93 20.31 19.48 17.98 16.33 14.28 15.96 21.51 - 17.98
Days Payable Outstanding (DPO)
44.47 33.79 27.89 35.55 41.61 37.27 25.47 31.85 39.91 - 40.03
Cash Conversion Cycle (CCC)
47.24 69.32 43.08 41.04 48.38 56.42 35.63 35.70 44.42 - 38.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-113 -171 -260 -282 -149 -128 -254 -238 -148 -109 -71
Invested Capital Turnover
-32.80 -22.86 -13.11 -13.86 -23.52 -21.23 -12.67 -12.87 -23.45 - -24.23
Increase / (Decrease) in Invested Capital
-51 -94 -71 -130 -37 43 5.56 44 1.32 19 183
Enterprise Value (EV)
9,645 11,909 15,340 15,922 15,136 20,681 14,099 16,258 30,886 - 22,155
Market Capitalization
10,906 13,350 16,973 17,657 16,696 22,116 15,597 17,816 32,436 - 23,668
Book Value per Share
$3.68 $4.02 $4.23 $4.47 $4.30 $4.00 $3.82 $4.04 $4.27 $4.38 $4.36
Tangible Book Value per Share
$2.40 $2.77 $3.03 $3.27 $3.13 $2.84 $2.66 $2.90 $3.13 $3.25 $3.24
Total Capital
1,248 1,370 1,474 1,553 1,511 1,406 1,344 1,319 1,403 1,446 1,442
Total Debt
100 100 100 100 100 100 100 0.00 0.00 0.00 0.00
Total Long-Term Debt
100 100 100 100 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-1,261 -1,441 -1,634 -1,735 -1,560 -1,434 -1,498 -1,557 -1,551 -1,555 -1,513
Capital Expenditures (CapEx)
45 44 49 60 62 56 72 62 63 67 68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-342 -399 -503 -550 -434 -451 -573 -547 -484 -394 -341
Debt-free Net Working Capital (DFNWC)
1,009 1,132 1,221 1,270 1,215 1,071 1,006 990 1,047 1,154 1,163
Net Working Capital (NWC)
1,009 1,132 1,221 1,270 1,115 971 906 990 1,047 1,154 1,163
Net Nonoperating Expense (NNE)
-4.60 -12 5.77 -16 -14 -9.28 915 -43 -9.83 -19 -9.90
Net Nonoperating Obligations (NNO)
-1,261 -1,441 -1,634 -1,735 -1,560 -1,434 -1,498 -1,557 -1,551 -1,555 -1,513
Total Depreciation and Amortization (D&A)
32 33 34 36 28 29 34 36 38 40 40
Debt-free, Cash-free Net Working Capital to Revenue
-11.99% -14.09% -17.12% -18.29% -14.08% -14.24% -17.62% -16.33% -13.90% - -8.67%
Debt-free Net Working Capital to Revenue
35.40% 40.00% 41.62% 42.20% 39.47% 33.80% 30.92% 29.56% 30.06% - 29.55%
Net Working Capital to Revenue
35.40% 40.00% 41.62% 42.20% 36.22% 30.64% 27.84% 29.56% 30.06% - 29.55%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.22 $0.22 ($0.11) $0.11 $0.19 $0.14 ($0.04) $0.14 $0.17 $0.30 $0.07
Adjusted Weighted Average Basic Shares Outstanding
314.15M 311.83M 322.59M 326.33M 327.68M 325.77M 326.54M 327.59M 329.57M 328.54M 331.15M
Adjusted Diluted Earnings per Share
$0.21 $0.22 ($0.11) $0.10 $0.19 $0.13 ($0.04) $0.14 $0.16 $0.29 $0.07
Adjusted Weighted Average Diluted Shares Outstanding
330.26M 332.57M 322.59M 343.44M 340.56M 342.70M 326.54M 337.73M 345.75M 342.99M 343.49M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
315.97M 324.91M 325.23M 327.69M 326.24M 326.02M 326.83M 328.64M 330.17M 330.46M 332.40M
Normalized Net Operating Profit after Tax (NOPAT)
66 69 -18 20 49 33 -22 4.54 45 81 14
Normalized NOPAT Margin
8.62% 8.69% -2.61% 2.62% 5.95% 3.77% -2.80% 0.53% 4.66% - 1.35%
Pre Tax Income Margin
10.41% 8.96% -3.99% 5.80% 9.25% 6.18% 0.06% 5.87% 6.81% - 3.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
258.51% 221.50% 70.32% 32.18% 156.82% 350.37% 386.62% 385.18% 312.53% - 135.61%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused snapshot of PSTG (Pure Storage) quarterly results from the last four years. The bullets highlight notable trends in revenue, margins, cash flow, and balance-sheet health that may impact a retail investor’s view on the stock.

  • Revenue growth: Q4 2026 revenue was $1,058,903,000, up from $879,842,000 in Q4 2025, reflecting expanding scale over the last four years.
  • Gross margin strength: Total Gross Profit margins remained robust around 70% in 2026 (e.g., ~69.9% in Q4 2026 and ~72.3% in Q3 2026), signaling solid pricing and cost discipline.
  • Profitability improving in late 2026: Net income attributable to common shareholders was $100,252,000 in Q4 2026 and $54,806,000 in Q3 2026, indicating a clear upward trend in profitability.
  • Strong operating cash flow: Net cash from continuing operating activities was $283.94M (Q1 2026), $212.16M (Q2 2026), $115.99M (Q3 2026), and $267.999M (Q4 2026), all positive.
  • Healthy liquidity with no debt: Long-term debt is zero and cash + short-term investments around $1.5B across 2026, supporting near-term liquidity against current liabilities (~$1.6B in many 2026 quarters).
  • Capital returns: PSTG repurchased common equity in multiple 2026 quarters, totaling roughly $180M, signaling management’s confidence and value return to shareholders.
  • Revenue visibility via deferred revenue: Current deferred revenue near $1.0B each quarter (around $1.028B in Q1 and Q3 2026, ~$1.006B in Q2 2026), suggesting revenue visibility from upfront cash receipts.
  • R&D investment remains meaningful and steady: R&D expenses ran roughly in the $221M–$256M range per quarter in 2026, supporting ongoing product development and potential long-term growth.
  • Quarterly earnings volatility: Earnings can swing from quarter to quarter (e.g., Q1 2026 showed a loss before returning to profits later in the year), indicating some volatility in quarterly profitability.
  • Q1 2026 net loss: Q1 2026 posted a net loss of about $13.99M, highlighting quarterly earnings volatility that investors may want to monitor as the business cycle evolves.
06/17/26 08:38 PM ETAI Generated. May Contain Errors.

Everpure Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Everpure's financial year ends in February. Their financial year 2026 ended on February 1, 2026.

Everpure's net income appears to be on a downward trend, with a most recent value of $188.18 million in 2026, falling from -$221.53 million in 2016. The previous period was $106.74 million in 2025. View Everpure's forecast to see where analysts expect Everpure to go next.

Everpure's total operating income in 2026 was $114.82 million, based on the following breakdown:
  • Total Gross Profit: $2.58 billion
  • Total Operating Expenses: $2.46 billion

Over the last 10 years, Everpure's total revenue changed from $739.17 million in 2016 to $3.66 billion in 2026, a change of 395.5%.

Everpure's total liabilities were at $3.23 billion at the end of 2026, a 21.5% increase from 2025, and a 666.3% increase since 2016.

In the past 10 years, Everpure's cash and equivalents has ranged from $183.68 million in 2016 to $854.87 million in 2026, and is currently $854.87 million as of their latest financial filing in 2026.

Over the last 10 years, Everpure's book value per share changed from 2.39 in 2016 to 4.38 in 2026, a change of 82.9%.



Financial statements for NYSE:P last updated on 6/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners